Objective: Electrospinning is a promising technology that provides biodegradable nanofiber scaffolds for cardiovascular tissue engineering. However, success with these materials has been limited, and the optimal combination of scaffold parameters for a tissue-engineered vascular graft (TEVG) remains elusive. The purpose of the present study is to evaluate the effect of bone marrow mononuclear cell (BM-MNC) seeding in electrospun scaffolds to support the rational design of optimized TEVGs.
Introduction
Electrospinning has been increasingly explored as a fabrication method to create seamless biodegradable tubular scaffolds for vascular tissue engineering, with applications ranging from surgical reconstruction of congenital cardiac anomalies to small diameter bypass grafting in atherosclerotic coronary artery disease. [1] [2] [3] [4] Electrospinning is a rapid, reproducible, and highly customizable technique that can be used to fabricate scaffolds of various geometries. 5 Varying electrospinning process parameters can yield tissueengineered scaffolds made of dry, nonwoven polymer fibers, ranging in diameter from 50nm to 20µm, smaller than what most other available fiber spinning techniques can produce. 3 The nanoarchitecture of electrospun scaffolds is especially relevant in tissue engineering as it mimics native extracellular matrix (ECM) in scale, which is thought to encourage cellular ingrowth, ECM deposition, and neotissue formation. 6 However, the sequential layering of nanofibers in the construction of tubular TEVG scaffolds produces constructs with three-dimensional pore sizes that are limited by fiber diameter. The effect of small pores (<10m) in TEVG scaffolds has been recently explored, and most published reports indicate that small pores inhibit cellular infiltration, delay degradation, and support chronic inflammation. [7] [8] [9] [10] [11] The latter aspect hinders the immune-mediated process of neovessel formation 7, 12, 13 which in turn may support adverse remodeling such as calcification or chronic intimal hyperplasia. Despite the fact that many innovative electrospun homopolymers, copolymers, and polymer blends have been created in response to these challenges, there is no electrospun scaffold design that has been translated to clinical application. 6 The first human clinical trial investigating the use of TEVGs in children with congenital heart defects began in 2001. 14 Highly porous biodegradable polymeric scaffolds, comprised of poly(L-lactide-co-ε-caprolactone) (PLCL) reinforced by polyglycolic acid (PGA) mesh 15 , were seeded with bone marrow mononuclear cell (BM-MNC). There is now established clinical evidence to show that TEVGs are safe and effective to use in pediatric patients undergoing extracardiac total cavopulmonary connection procedure. 16, 17 Tissue This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
In this report, we fabricated a co-electrospun scaffold from PGA and PLCL modeled after those materials recently reported in human trial. 3, [15] [16] [17] Due to reports of BM-MNC seeding preventing TEVG stenosis in other scaffold types, 18 we investigated whether BM-MNC seeding prior to implant improved the performance of electrospun scaffolds in a murine venous interposition model over a 6-month time course.
Materials and Methods

Animal care and ethics statement
All animals received humane care in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The Institutional Animal Care and Use Committee of the Research Institute at Nationwide Children's Hospital approved and monitored all animal procedures described in this report. Thirty-five C57BL/6 mice (17-20g, 8-12 week old, female) were purchased from Jackson Laboratories (Bar Harbor, ME).
Graft fabrication
To create the co-electrospun polyglycolic acid (PGA) and polylactide-cocaprolactone (PLCL) scaffolds, 10 wt% PGA was dissolved in hexafluoroisopropanol and 5
wt% PLCL was dissolved in hexafluoroisopropanol. Each solution was stirred via a magnetic stir bar for at least 3 hours at room temperature. In separate syringes, the PGA solution was dispensed at a flow rate of 2.5 mL/hour and the PLCL solution was dispensed at a flow rate of 5.0 mL/hour to create grafts with a 1:1 PGA:PLCL weight ratio. Both solutions were simultaneously electrospun onto the mandrel that was positioned 20 cm from the needle tips and rotated at 30 RPM. A +25 kV charge was applied to each syringe tip and electrospun nanofibers were deposited onto the grounded mandrel until the desired wall thickness of 0.1mm was achieved. The electrospun scaffold was then removed from the mandrel and the wall thickness measured with a digital snap gauge by placing the scaffold between two glass slides. The PGA/PLCL tubes were cut into 5mm lengths and the inner This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
diameter was 1mm. The scaffolds were then packaged in Tyvek pouches and sterilized with 25 kGy of gamma irradiation.
Scaffold degradation
Electrospun sheets were prepared from the same co-electrospinning setup as used to produce the tubes for this experiment, except the fibers were deposited onto a flat plate to a thickness of approximately 250 µm. The scaffold degradation samples were 250um thick to follow the guidelines outlined in the American Society for Testing and Materials Standard Test Method for Tensile Properties of Plastics (ASTM D638). The difference in thickness does not affect the mechanics of the graft as we report the ultimate tensile strength (UTS) in MPa which is independent of scaffold thickness. The degradation rate is not affected by the scaffold thickness because the construct is completely porous.
The thickness of every test sample was measured prior to testing. A digital caliper (VWR)
with an accuracy of two decimal places was zeroed on two 3" x 1" x 1 mm glass microscope slides (VWR). Samples were placed between the glass slides, and the thicknesses were measured following ASTM standard D6988-13. Three measurements were taken, one on the right, center, and left of each sample. The median of these three measurements was recorded in millimeters as the thickness of the sample.
Five tensile dogbones were cut from the electrospun sheets according to ASTM D638 Type V using a universal testing machine (MultiTest 5-i, Mecmesin Corporation). For the in vitro degradation, a single tensile dogbone was placed in a glass vial with 25 mL of phosphate buffered saline (PBS). Five samples per timepoint were placed in an incubator and held at a constant 37°C until they were withdrawn for mechanical testing. The ends of each dogbone sample were clamped to opposite arms of the testing machine and pulled apart until failure. The peak load from each sample was averaged and recorded in MPa as the ultimate tensile strength (UTS). The elongation to failure of each sample was also recorded as % of original sample length. Young's modulus of each sample was determined from the slope of the linear regime of the resulting stress-strain curve and recorded in MPa. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Bone marrow harvest and graft seeding
Clinically, we have already used BM-MNCs as a cell source. 16 Bone marrow donor mice (n = 5) were administered an overdose cocktail of ketamine (300mg/kg) and xylazine (30mg/kg). Their bone marrow was harvested, the MNC population enriched, and scaffolds seeded as previously described. 18, 20 Briefly, hind limbs were disarticulated in sterile fashion, muscle and tendon dissected, and the femoral and tibial heads were removed. Bone marrow was collected by repeated flushing with 5.0mL of RPMI 1640 (Sigma) + 1% penicillin/streptomycin (P/S, Sigma). The pooled bone marrow was filtered to remove bone spicules and macroaggregates (100μm cell strainer, Fisher). This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Graft implantation
Seeded or unseeded scaffolds (n=15/group) were implanted as infrarenal inferior vena cava (IVC) interposition grafts following standard microsurgical technique as previously described. 18, 20, 21 Briefly, mice were administered a pre-anesthesia analgesic of ketoprofen (5mg/kg, IP) and anesthetized with a cocktail of ketamine (100mg/kg, IP) and xylazine (10mg/kg, IP). Scaffolds (5.0 mm length) were interposed end-to-end with 10-0 nylon suture in running fashion. After confirming patent anastomosis and ensuring hemostasis, the abdomen was closed in two layers with 6-0 prolene suture in running fashion. Animals were followed for 6 months without anti-platelet or anti-coagulation therapy. There was no operative and graft related mortality at any point during follow up.
Ultrasound interrogation
Implanted grafts were monitored longitudinally until explant (2, 4, 8, 12 , and 24
weeks after implantation) with high frequency Doppler ultrasonography (Vevo ® 2100, VisualSonics Inc., Toronto, Canada). Anesthesia was induced with 1.5% inhaled isoflurane vaporized with 100% O 2 at a rate of 1L/min. Body temperature was maintained at 38°C and vitals were maintained within normal limits for the duration of ultrasound examination.
Long axis images were acquired with B-mode, pulse-wave, and color Doppler. ImageJ (NIH, Bethesda, MD) was used to quantify lumen diameter of B-mode images and graft patency was determined with pulse-wave and color Doppler images as previously described. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
7-3. RT-qPCR
Frozen tissue blocks were sliced (30μm thick sections) on a CM1950 cryostat (Leica Biosystems, Buffalo Grove, IL). Sections were washed in 1x PBS to remove excess OCT compound and total RNA was extracted and purified using the RNeasy mini kit (Qiagen). Reverse transcription was performed using the High Capacity RNA-to-cDNA Kit This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
9. In vitro analyses 9-1. DNA assay
The fluorometric Quant-iT™ PicoGreen® dsDNA Assay Kit (Life Technologies) was used following the manufacturer's protocol to monitor cell seeding (n=5, seeded scaffolds). Fluorescence intensity measurements were acquired with a SpectraMax M5
Microplate reader (Excitation 488nm, Emission 525nm, Molecular Devices) and applied to a standard curve. The efficacy of cell seeding was determined by the total number of cells in each well divided by the surface area of the scaffold (cells/ mm 2 ) as previously described. 18 9-2. Platelet isolation and ATP secretion assays Whole blood was harvested by cardiac puncture using a 25G needle and 3mL syringe pre-loaded with 100-200μL of citrate-dextrose solution (C3821, Sigma) and platelets were enriched as previously described. 22 Briefly, aspirated blood was centrifuged (120g, 8min) to separate erythrocytes and leukocytes from the platelet rich plasma (PRP).
PRP was aspirated and centrifuged (120g, 3min) to further enrich the platelet fraction. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Statistical Analysis
Lumen diameter measurements derived from serial ultrasound imaging were analyzed via two-way ANOVA with Tukey's correction for multiple comparisons.
Histomorphometric quantifications of lumen diameter were compared with nonparametric unpaired two-tailed Mann Whitney t-test, as the data were not normally distributed. The incidence of stenosis between both groups was compared with a twosided Chi-square test. F4/80 + cell counts and SEM measurements of fiber diameter and pore size were analyzed with a parametric unpaired two-tailed t-test. iNOS and CD206 IHC and PCR, eNOS and ACTA2 PCR, and ATP secretion data were compared within and across groups by two-way ANOVA with Tukey's correction for multiple comparisons. p < 0.05 was considered statistically significant.
Results
PGA/PLCL scaffolds comprised of nanofibers forming pores of < 10µm
The mean fiber diameter and pore size of the PGA/PLCL electrospun scaffold for to 324 ± 39% after 1 week, increased to 832 ± 20% after 4 weeks, and then finally decreased to 46 ± 8% at 12 weeks (Fig .1G, H, I ). This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. (Fig. 3 F, J ).
BM-MNC seeding modulates host inflammation
Immunohistochemical staining for F4/80 + macrophages demonstrated significantly less macrophage infiltration in seeded scaffolds at 6 months ( Fig. 4 A, B , G, p < 0.05). Regarding macrophage phenotype (Fig. 4C-F) , there was a trend that the number of iNOS positive cells in seeded scaffolds was smaller than that in unseeded scaffolds, which did not reach statistical difference (Fig. 4H , p = 0.14). The number of CD206 positive cells was significantly higher in seeded scaffolds (Fig. 4H , p < 0.0001). This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Cell-seeded nanofiber scaffolds support formation of well-organized luminal neotissue
Immunofluorescent analysis of TEVG neotissue indicated the formation of wellorganized neo-intima in the seeded group characterized by a medial -SMA + smooth muscle cell layer lined by a CD31 + endothelial cell monolayer (Fig. 5 A-B) . Subsequent staining for SM-MHC in the seeded group confirmed that the luminal smooth muscle cells were mature and contractile (Fig. 5 B inset) . As expected, the unseeded TEVG neotissue was characterized by an unorganized population of -SMA + and CD-31 + cells (Fig. 5 C) , and evidence of re-canalization was appreciated (Fig. 5 D) . RT-qPCR indicated less ACTA2 gene transcription and significantly more eNOS transcription in the seeded group (Fig. 5 E, This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Discussion
The results of this study demonstrated the effect of BM-MNC seeding in a novel electrospun vascular graft. BM-MNC seeding of nanofiber scaffolds prevented stenosis, compared to unseeded scaffolds over 6 months. The patent vascular grafts showed concentric laminated smooth muscle cells, a confluent endothelial monolayer, and collagen rich ECM. Platelet derived ATP was significantly reduced after incubating thrombin-activated platelets in the presence of BM-MNC seeded nanofiber scaffolds compared to unseeded scaffolds. Macrophage infiltration into the cell-seeded grafts was significantly less than unseeded grafts. These data suggest that BM-MNC seeding on nanofiber vascular grafts attenuated stenosis through the prevention of host macrophage infiltration and platelet function, which led to well-organized neotissue formation.
Cell seeding reduces monocyte/macrophage infiltration, expression of proinflammatory markers, and promotes TEVG patency and longevity. 7, 12, 18 We have previously demonstrated that BM-MNC cell seeding effectively attenuates intimal hyperplasia in both murine 7, 12, 18 and ovine 24, 25 models, and that this effect is doseresponsive. 18 However, the scaffolds used in previous reports consisted of a non-woven PGA felt sealed with a polymer solution of PLCL 26 which yielded a microarchitecture permitting a relatively high degree of cell infiltration (pore size: 45.54  17.6m), rapid degradation kinetics (loss of tensile strength by 8 weeks), with favorable growth and remodeling over the time course of implantation. 27, 28 The model scaffold examined in this report had a much smaller fiber diameter (0.61  0.24m) and pore size (9.12  3.15m) than previous studies, which represents many electrospun constructs examined in recent literature. 3 Despite much smaller pore size of the scaffold, the role of cell seeding to attenuate inflammation and prevent graft stenosis was similar. These data indicate that the beneficial effects of BM-MNC seeding may, at least to a certain degree, be independent of scaffold type. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
seeded into TEVGs reduced the overall influx of macrophages and the magnitude of M1 activation. Moreover, macrophages that infiltrate cell-seeded grafts do not undergo M1 to M2 transition, as was observed in unseeded grafts. 12 It is noted by F4/80 staining, that macrophage infiltration was present in both seeded and unseeded grafts at 6 months due to remaining nanofiber scaffolds, however, this was significantly less in the seeded grafts.
Interestingly, by iNOS and CD206 staining, there was higher M2 macrophage infiltration and lower M1 macrophage infiltration noted in the seeded scaffolds compared to the unseeded scaffolds. Daley et al. reported wound-healing macrophages with features of both M1 and M2 activation. 31 Therefore, macrophages that populate cell-seeded grafts assume a unique activation state promoting remodeling, that is yet to be defined. If we can find specific markers of macrophage subtypes that affect graft patency, these would be useful for predicting graft stenosis in the clinical setting.
More recently, the regulation of platelet activity by seeded BM-MNCs has been considered, and significant platelet activation, aggregation, and mural thrombus formation/fibrin deposition is thought to initiate an inflammatory cascade leading to This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
BM-MNC seeding for nanofiber vascular graft led to the attenuation of inflammation and prevention of graft stenosis, as demonstrated by high M2 and low M1 macrophages infiltration and reduction of measurable platelet-derived ATP in vitro.
While the results of this study are promising and clearly encourage further investigation, this experiment was limited by the small animal model and seeding technique in this study. We utilized a murine model for vascular graft implantation, however the typical lifespan of mice is up to 1 to 1.5 years. It is difficult to perform longterm experiments in mice with nanofiber scaffolds.
Conclusion
BM-MNC seeding of electrospun TEVG scaffolds prevents stenosis by modulating host macrophage and platelet function. To our knowledge, we are the first to report the prevention of platelet activation using BM-MNC seeded nanofiber biodegradable scaffolds.
Incorporating BM-MNC seeding into novel electrospinning approaches for cardiovascular tissue engineering may improve patency in the venous circulation and allow for the rational design of an optimized electrospun TEVG. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
